Los Angeles, CA (February 12, 2019) – Okyanos Global Health CEO Dr. Marc Penn discusses stem cell therapies offered at Okyanos Center for Regenerative Medicine on the internationally syndicated series, Worldwide Business with kathy ireland®*. Dr. Penn, MD, PhD, FACC detailed Okyanos’s commitment to safety, innovation and improving the lives of its patients through regenerative medicine.
When Ms. Ireland asked about Okyanos’s unique business model and approach to regenerative medicine Dr. Penn said, “At Okyanos Global Health, Kathy, what we’ve really developed is a platform that has three pillars:
- We help young medtech (or biotech) companies complete their device or their drug or their biologic and get it ready for translation into clinical populations.
- We then work with them to get through the Bahamian regulatory cycle and to get the protocols approved.
- Something I’m quite passionate about as a father of three and widower of somebody who died too young, we get these technologies offered to patients who have chronic illness in an attempt to get them help but also help the company develop early human data–to understand if their technology is right or works–BUT we do that with a laser focus on safety.”
View full press release on Digital Journal.
*The segment above aired on Fox Business Network and Bloomberg International Networks as sponsored content.